07:00 , Aug 18, 1997 |  BC Week In Review  |  Clinical News

Chiron regulatory update

Chiron Corp. (CHIR), Emeryville, Calif.   Business: Diagnostics/Imaging   CHIR's Chiron Diagnostics unit (East Walpole, Mass.) received 510(k) marketing clearance from the FDA for its ACS:Centaur Chemiluminescent Immunoassay System for use as an immunodiagnostic system...
07:00 , Jun 30, 1997 |  BC Week In Review  |  Clinical News

Truquant BR Radioimmunoassay for the CA 27 data

A three-year trial tested 166 women previously treated for stage II and III cancer, demonstrating sensitivity of 57.7 percent and specificity of 97.9 percent, as reported in the Journal of Clinical Oncology. Positive predictive value...